Last reviewed · How we verify
NCT07183475: RTS
Return to Sports After Knee Arthroplasty
NA trial testing Return to sports test in Knee Osteoarthristis in 50 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Technical University of Munich |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 50 |
| Start date | 15 July 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 July 2027 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Return to sports test
Conditions studied
- Knee Osteoarthristis — all drugs for Knee Osteoarthristis →
- Arthroplasty Replacement, Knee — all drugs for Arthroplasty Replacement, Knee →
Sponsor
Technical University of Munich
Who can join
Adults 18 to 85, any sex, with Knee Osteoarthristis or Arthroplasty Replacement, Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The ability to return to sports after joint arthroplasty is increasingly becoming an important factor for patients in terms of their perceived quality of life. In sports orthopaedics, standardized functional tests have already been established - particularly for anterior cruciate ligament injuries - to assess athletic performance and prevent re-injury. These tests allow a stepwise evaluation of a subject's physical readiness for sports. In the field of arthroplasty, and despite increasing sports activity among patients with joint arthroplasty such structured assessment is still lacking. As a result, patients with arthroplasty typically resume sports activities based solely on individual recommendations from the surgeon or treating therapist. However, an objective evaluation of sports capability is currently not available. Therefore the amendment intends to expand the current testing protocol of the already registered and ongoing study (Protocol ID: UBonn\_TKA\_FollowUp) to include additional standardized, evidence-based return-to-sprort-tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07183475
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Osteoarthristis
Currently open trials in the same condition.
- NCT07396233 — Effects of Diagonal Proprioceptive Neuromuscular Facilitation Patterns on Pain and Functional Outcomes in Patients With · NA · recruiting
- NCT07416357 — The Validity and Reliability of the OMERACT in the Turkish Population · recruiting
- NCT07367126 — Neuropathic Pain in Knee Osteoarthritis: Pain Severity and Functional Status · recruiting
- NCT07329361 — Efficacy and Safety of Intra-articular Injections of Frozen Platelet-Rich Plasma in Patients With Knee Osteoarthritis · NA · recruiting
- NCT07319546 — Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty · NA · recruiting
Other Technical University of Munich trials
Trials by the same sponsor.
- NCT07519811 — LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
- NCT07077005 — Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy · NA · recruiting
- NCT07212699 — Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an App · NA · recruiting
- NCT06823271 — Haemodynamics and Ventricular Arrhythmias During Exercise in Patients With Arrhythmogenic Cardiomyopathy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07183475 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Technical University of Munich
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07183475.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing